Papillary Renal Cell Carcinoma

Also known as: Papillary Renal Cell Carcinoma (Prcc) / Renal Cell Carcinoma of Papillary Histology / Papillary Cell Renal Carcinoma / Renal Papillary Cell Carcinoma / Papillary renal cell carcinoma (morphologic abnormality) / Papillary renal cell carcinoma (disorder) / Papillary adenocarcinoma (morphologic abnormality) / Adenocarcinoma, Papillary

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB17551	AGS-16C3F	1	Completed	1
DB00112	Bevacizumab	1 / 2	Completed	1
DB00398	Sorafenib	1 / 2	Completed	1
DB11595	Atezolizumab	2	Recruiting	1
DB06626	Axitinib	2	Completed	1
DB11105	Benzalkonium	2	Terminated	1
DB00112	Bevacizumab	2	Recruiting	1
DB08875	Cabozantinib	2	Active Not Recruiting	2
DB08875	Cabozantinib	2	Recruiting	3
DB00958	Carboplatin	2	Completed	1
DB00531	Cyclophosphamide	2	Completed	1
DB00970	Dactinomycin	2	Completed	1
DB00997	Doxorubicin	2	Completed	1
DB11714	Durvalumab	2	Active Not Recruiting	1
DB00530	Erlotinib	2	Recruiting	1
DB00773	Etoposide	2	Completed	1
DB01590	Everolimus	2	Completed	1
DB09398	Fluoride ion F-18	2	Recruiting	1
DB05258	Interferon alfa	2	Terminated	1
DB00034	Interferon alfa-2a	2	Terminated	1
DB00105	Interferon alfa-2b	2	Terminated	1
DB00018	Interferon alfa-n3	2	Terminated	1
DB06186	Ipilimumab	2	Recruiting	2
DB00762	Irinotecan	2	Completed	1
DB09035	Nivolumab	2	Active Not Recruiting	1
DB09035	Nivolumab	2	Recruiting	2
DB14769	Pamiparib	2	Withdrawn	1
DB06589	Pazopanib	2	Active Not Recruiting	1
DB09037	Pembrolizumab	2	Completed	1
DB12048	Savolitinib	2	Active Not Recruiting	1
DB00398	Sorafenib	2	Terminated	1
DB01268	Sunitinib	2	Active Not Recruiting	1
DB00853	Temozolomide	2	Withdrawn	1
DB11771	Tremelimumab	2	Active Not Recruiting	1
DB00541	Vincristine	2	Completed	1
DB11714	Durvalumab	3	Recruiting	1
DB09037	Pembrolizumab	3	Not Yet Recruiting	1
DB12048	Savolitinib	3	Recruiting	1
DB01268	Sunitinib	3	Recruiting	1